The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges
Publisher Name » GBI Research
Published Date » 2010-03-15
No. Of Pages » 141
GBI Research has released its research - “The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.
- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in the various phases of drug development.
- Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.
- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 10
2 Global Pain Management Therapeutics Market: Introduction 13
2.1 GBI Research Report Guidance 13
3 Global Pain Management Therapeutics Market: Market Overview 14
3.1 Introduction 14
3.2 Revenue Forecast for the Global Pain Management Therapeutics Market 15
3.2.1 Sales Value 15
3.2.2 Patient Volume 16
3.2.3 Annual Cost of Therapy 17
3.2.4 Treatment Usage Patterns 18
3.2.5 Generics Share in the Global Pain Management Therapeutics Market 23
3.2.6 Sales of Leading Drugs 24
3.3 Pain Management Therapeutics Market Drivers 25
3.3.1 Increase in Diagnosed and Prescription Population 25
4 Global Pain Management Therapeutics Market: Therapeutic Landscape 26
4.1 Fibromyalgia Market 26
4.1.1 Introduction 26
4.1.2 Sales Value 26
4.1.3 Patient Volume 28
4.1.4 Annual Cost of Therapy 29
4.1.5 Treatment Usage Patterns 30
4.1.6 Drivers for Fibromyalgia Pain Market 35
4.1.7 Restraints for Fibromyalgia Pain Market 36
4.1.8 Unmet Needs 36
4.2 Neuropathic Pain Market 36
4.2.1 Introduction 36
4.2.2 Sales Value 37
4.2.3 Patient Volume 38
4.2.4 Annual Cost of Therapy 39
4.2.5 Treatment Usage Patterns 40
4.2.6 Drivers for Neuropathic Pain Market 45
4.2.7 Restraints for Neuropathic Pain Market 46
4.2.8 Unmet Need 46
4.3 Migraine Market 46
4.3.1 Introduction 46
4.3.2 Sales Value 47
4.3.3 Patient Volume 48
4.3.4 Annual Cost of Therapy 49
4.3.5 Treatment Usage Patterns 50
4.3.6 Drivers for Migraine Market 55
4.3.7 Restraints for Migraine Market 55
4.3.8 Unmet Need 56
4.4 Cancer Pain Market 56
4.4.1 Introduction 56
4.4.2 Sales Value 56
4.4.3 Patient Volume 58
4.4.4 Annual Cost of Therapy 59
4.4.5 Treatment Usage Patterns 60
4.4.6 Drivers for Cancer Pain Market 64
4.4.7 Restraints for Cancer Pain Market 65
4.4.8 Unmet Need 65
4.5 Osteoarthritis Pain Market 65
4.5.1 Introduction 65
4.5.2 Sales Value 66
4.5.3 Patient Volume 67
4.5.4 Annual Cost of Therapy 68
4.5.5 Treatment Usage Patterns 69
4.5.6 Drivers for Osteoarthritis Pain Market 73
4.5.7 Restraints for Osteoarthritis Pain Market 74
4.5.8 Unmet Need 74
5 Global Pain Management Therapeutics Market: Geographical Landscape 75
5.1 Geographical Break-up 75
5.2 The US 77
5.2.1 Sales Value 77
5.2.2 Patient Volume 78
5.2.3 Annual Cost of Therapy 79
5.2.4 Treatment Usage Patterns 80
5.3 Top Five Countries in Europe 85
5.3.1 Sales Value 85
5.3.2 Patient Volume 86
5.3.3 Annual Cost of Therapy 87
5.3.4 Treatment Usage Patterns 88
5.4 Japan 93
5.4.1 Sales Value 93
5.4.2 Patient Volume 94
5.4.3 Annual Cost of Therapy 95
5.4.4 Treatment Usage Patterns 96
6 Global Pain Management Therapeutics Market: Pipeline Analysis 102
6.1 Introduction 102
6.1.1 Research and Development Pipeline Fibromyalgia 103
6.1.2 Research and Development Pipeline Neuropathic Pain 104
6.1.3 Research and Development Pipeline Migraine 105
6.1.4 Research and Development Pipeline Cancer Pain 106
6.1.5 Research and Development Pipeline Osteoarthritis Pain 106
6.2 Profiles of Key Late-Stage Drugs in the Pain Management Market 107
6.2.1 Droxopida 107
6.2.2 Xyrem 107
6.2.3 Vimpat (lacosamide) 107
6.2.4 Qutenza (capsaicin 8%) 108
6.2.5 Botox 109
6.2.6 Tezampanel 110
6.2.7 Nasalfent 110
6.2.8 PF-4383119 (Tanezumab) 111
7 Global Pain Management Therapeutics Market: Competitive Landscape 112
7.1 Market Share Analysis 112
7.2 Competitive Profiling 112
7.2.1 Pfizer, Inc. 114
7.2.2 Eli Lilly and Company 115
7.2.3 Johnson & Johnson 117
7.2.4 Endo Pharmaceuticals 119
7.2.5 Novartis AG 120
7.2.6 Merck & Co Inc 122
7.2.7 Cephalon, Inc. 123
8 Global Pain Management Therapeutics Market: Strategic Consolidations 125
8.1 Overview 125
8.1.1 Sanofi-Aventis Acquired 100% outstanding shares of Chattem, Inc in December 2009 127
8.1.2 Dainippon Sumitomo Pharma Acquired Sepracor, Inc. in October 2009 127
8.1.3 Raptor Pharmaceuticals and TorreyPines Therapeutics Merged in August 2009 127
8.1.4 Alexza Pharmaceuticals Acquired Symphony Allegro in June 2009 127
8.1.5 Anesiva and Arcion Therapeutics Merge in May 2009 127
8.1.6 Mylan Laboratories Acquired Matrix Laboratories Limited in March 2009 128
8.2 R&D Licensing Agreements 128
8.2.1 Deals by Indication 128
8.2.2 Deals by Phase 129
8.2.3 Deals by Geography 130
8.2.4 Deals by Value ($) 131
8.2.5 Preclinical and Discovery 131
8.2.6 Phase I 132
8.2.7 Phase II 132
8.2.8 Phase III 133
8.2.9 Approved and Regulatory Filing 134
9 Global Pain Management Therapeutics Market: Appendix 136
9.1 Market Definitions 136
9.2 Abbreviations 136
9.3 Research Methodology 137
9.3.1 Coverage 137
9.3.2 Secondary Research 138
9.3.3 Primary Research 138
9.3.4 Forecasts 138
9.3.5 Expert Panel Validation 140
9.4 Contact Us 141
9.5 Disclaimer 141
9.6 Sources 141
Table 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2009
Table 2: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2009-2016
Table 3: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2001-2009
Table 4: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2009-2016
Table 5: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2001-2009
Table 6: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2009-2016
Table 7: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009
Table 8: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016
Table 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016
Table 10: Pain Management Therapeutics Market, Global, Sales of Leading Drugs, 2009
Table 11: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2001-2009
Table 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2009-2016
Table 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2009
Table 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2009-2016
Table 15: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2009
Table 16: T Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2009-2016
Table 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009
Table 18: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2009-2016
Table 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2001-2009
Table 20: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2009-2016
Table 21: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2001-2009
Table 22: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2009-2016
Table 23: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2001-2009
Table 24: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2009-2016
Table 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2001-2009
Table 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2009-2016
Table 27: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn), 2001-2009
Table 28: Pain Management Therapeutics Market, Global, Migraine Diseases Population ($ bn), 2009-2016
Table 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2009
Table 30: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2009-2016
Table 31: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2009
Table 32: Pain Management Therapeutics Market, Global, Annual Cost of Migraine Treatment ($), 2001-2009
Table 33: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2001-2009
Table 34: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2009-2016
Table 35: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2001-2009
Table 36: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2009-2016
Table 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2009
Table 38: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2009-2016
Table 39: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2009
Table 40: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2009-2016
Table 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2001-2009
Table 42: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2009-2016
Table 43: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2001-2009
Table 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2009-2016
Table 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2001-2009
Table 46: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2009-2016
Table 47: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2009
Table 48: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2009-2016
Table 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2001-2009
Table 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2009-2016
Table 51: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009
Table 52: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016
Table 53: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2009
Table 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2009-2016
Table 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2009
Table 56: Pain Management Therapeutics Market, US, Patient Volume (million), 2009-2016
Table 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009
Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016
Table 59: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2001-2009
Table 60: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2009-2016
Table 61: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009
Table 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016
Table 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2009
Table 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2009-2016
Table 65: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009
Table 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016
Table 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2009
Table 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2009-2016
Table 69: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009
Table 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016
Table 71: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2001-2009
Table 72: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2009-2016
Table 73: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009
Table 74: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016
Table 75: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2009
Table 76: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions) , 2009-2016
Table 77: Pain Management Therapeutics Market, Global, Competitive Landscape, 2009
Table 78: Pain Management Therapeutics Market, Merck, Pipeline Products, December 2009
Table 79: Pain Management Therapeutics Market, Eli Lilly, Pipeline Products, 2010
Table 80: Pain Management Therapeutics Market, J&J, Pipeline Products, 2010
Table 81: Pain Management Therapeutics Market, Endo Pharmaceuticals, Pipeline Products, 2010
Table 82: Pain Management Therapeutics Market, Novartis, Pipeline Products, 2010
Table 83: Pain Management Therapeutics Market, Merck & Co, Inc., Pipeline Products, 2010
Table 84: Cephalon Inc. - Pain Pipeline Products, 2009
Table 85: Pain Management Therapeutics Market, Global, Major M&A Deals, 2009-2010
Table 86: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-2009
Table 87: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2009
Table 88: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2009
Table 89: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2009
Table 90: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs Which are Approved or Awaiting Approval, 2008-2009
Figure 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2000-2016 15
Figure 2: Pain Management Therapeutics Market, Global, Volume (Millions), 2001-2016 16
Figure 3: Pain Management Therapeutics Market, Global, Annual Cost of Therapy ($),
2000-2015 17
Figure 4: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 18
Figure 5: Pain Management Therapeutics Market, Global, Diseased Population (Millions),
2001-2016 19
Figure 6: Pain Management Therapeutics Market, Global, Treatment Seeking Population (Millions), 2001-2016 20
Figure 7: Pain Management Therapeutics Market, Global, Diagnosed Population (Millions), 2001-2016 21
Figure 8: Pain Management Therapeutics Market, Global, Prescription Population (Millions), 2001-2016 22
Figure 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 23
Figure 10: Pain Management Therapeutics Market, Global, Growth Parameters, 2009 25
Figure 11: Pain Management Therapeutics Market, Global, Sales Value by Indication (%) 2009 and 2016 26
Figure 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($ bn), 2001-2016 27
Figure 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2016 28
Figure 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2016 29
Figure 15: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 30
Figure 16: Pain Management Therapeutics Market, Global, Fibromyalgia Diseased Population (Millions), 2001-2016 32
Figure 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Seeking Population (Millions), 2001-2016 33
Figure 18: Pain Management Therapeutics Market, Global, Fibromyalgia Diagnosed Population (Millions), 2001-2016 34
Figure 19: Pain Management Therapeutics Market, Global, Fibromyalgia Prescription Population (Millions), 2001-2016 35
Figure 20: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2016 37
Figure 21: Pain Management Therapeutics Market, Global, Neuropathic Pain, Patient Volume (Millions), 2001-2016 38
Figure 22: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Therapy ($), 2001-2016 39
Figure 23: Pain Management Therapeutics Market, Global, Neuropathic Treatment Usage Patterns, 2001-2016 40
Figure 24: Pain Management Therapeutics Market, Global, Neuropathic Pain Diseased Population (Millions), 2001-2016 42
Figure 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Seeking Population (Millions), 2001-2016 43
Figure 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Diagnosed Population (Millions), 2001-2016 44
Figure 27: Pain Management Therapeutics Market, Global, Neuropathic Pain Prescription Population (Millions), 2001-2016 45
Figure 28: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn),
2001-2016 47
Figure 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2016 48
Figure 30: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2016 49
Figure 31: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions) , 2001-2016 50
Figure 32: Pain Management Therapeutics Market, Global, Migraine Diseased Population (Millions), 2001-2016 52
Figure 33: Pain Management Therapeutics Market, Global, Migraine Treatment Seeking Population (Millions), 2001-2016 53
Figure 34: Pain Management Therapeutics Market, Global, Migraine Diagnosed Population (Millions), 2001-2016 54
Figure 35: Pain Management Therapeutics Market, Global, Migraine Prescription Population (Millions), 2001-2016 55
Figure 36: Pain Management Therapeutics Market, Global, Cancer Pain Sales Value ($ bn),
2001-2016 57
Figure 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2016 58
Figure 38: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2016 59
Figure 39: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns, 2001-2016 60
Figure 40: Pain Management Therapeutics Market, Global, Cancer Pain Diseased Population, 2001-2016 61
Figure 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Seeking Population, 2001-2016 62
Figure 42: Pain Management Therapeutics Market, Global, Cancer Pain Diagnosed Population, 2001-2016 63
Figure 43: Pain Management Therapeutics Market, Global, Cancer Pain Prescription Population, 2001-2016 64
Figure 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($ bn), 2001-2016 66
Figure 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (Millions), 2001-2016 67
Figure 46: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2016 68
Figure 47: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns, 2001-2016 69
Figure 48: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diseased Population, 2001-2016 70
Figure 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Seeking Population, 2001-2016 71
Figure 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diagnosed Population, 2001-2016 72
Figure 51: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Prescription Population, 2001-2016 73
Figure 52: Pain Management Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 75
Figure 53: Pain Management Therapeutics Market, Global, Sales Value by Geography ($bn), 2001-2016 76
Figure 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2016 77
Figure 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2016 78
Figure 56: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 79
Figure 57: Pain Management Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 80
Figure 58: Pain Management Therapeutics Market, US, Diseased Population (Millions),
2001-2016 81
Figure 59: Pain Management Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 82
Figure 60: Pain Management Therapeutics Market, US, Diagnosed Population (Millions),
2001-2016 83
Figure 61: Pain Management Therapeutics Market, US, Prescription Population (Millions),
2001-2016 84
Figure 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value
($ bn), 2001-2016 85
Figure 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2016 86
Figure 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 87
Figure 65,: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2016 88
Figure 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 89
Figure 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions), 2001-2016 90
Figure 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 91
Figure 69: Pain Management Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 92
Figure 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 93
Figure 71: Pain Management Therapeutics Market, Japan, Patient Volume (million) , 2001-2016 94
Figure 72: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($),
2001-2016 95
Figure 73: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2016 96
Figure 74: Pain Management Therapeutics Market, Japan, Diseased Population (Millions),
2001-2016 98
Figure 75: Pain Management Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 99
Figure 76: Pain Management Therapeutics Market, Japan, Diagnosed Population (Millions),
2001-2016 100
Figure 77: Pain Management Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 101
Figure 78: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication, December 2009 102
Figure 79: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase, December 2009 102
Figure 80: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Fibromyalgia, March 2010 103
Figure 81: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Neuropathic Pain, March 2010 104
Figure 82: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Migraine, March 2010 105
Figure 83: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Cancer Pain, March 2010 106
Figure 84: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Osteoarthritis, March 2010 106
Figure 85: Pain Management Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 112
Figure 86: Pain Management Therapeutics Market, Global, Pfizer, Share of Key Pain Drugs Revenue, 2009 114
Figure 87: Pain Management Therapeutics Market, Global, Eli Lilly and Company, Share of Key Pain Drugs Revenue, 2009 116
Figure 88: Pain Management Therapeutics Market, Global, Johnson & Johnson, Share of Key Pain Drugs Revenue, 2009 118
Figure 89: Pain Management Therapeutics Market, Global, Endo Pharmaceuticals, Share of Key Pain Drugs Revenue, 2009 119
Figure 90: Pain Management Therapeutics Market, Global, Novartis, Share of Key Pain Drugs Revenue, 2009 121
Figure 91: Pain Management Therapeutics Market, Global, Merck & Co, Inc., Share of Key Pain Drugs Revenue, 2009 123
Figure 92: Pain Management Therapeutics Market, Global,Cephalon, Share of Key Pain Drugs Revenue, 2009 124
Figure 93: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Indication, 2008-2010 128
Figure 94: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Phase, 2008-2010 129
Figure 95: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-2010 130
Figure 96: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-2010, n=8 131
Figure 97: GBI Research Methodology, 2010 137
Figure 98: GBI Research Market Forecasting Model, 2010 140
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 10
2 Global Pain Management Therapeutics Market: Introduction 13
2.1 GBI Research Report Guidance 13
3 Global Pain Management Therapeutics Market: Market Overview 14
3.1 Introduction 14
3.2 Revenue Forecast for the Global Pain Management Therapeutics Market 15
3.2.1 Sales Value 15
3.2.2 Patient Volume 16
3.2.3 Annual Cost of Therapy 17
3.2.4 Treatment Usage Patterns 18
3.2.5 Generics Share in the Global Pain Management Therapeutics Market 23
3.2.6 Sales of Leading Drugs 24
3.3 Pain Management Therapeutics Market Drivers 25
3.3.1 Increase in Diagnosed and Prescription Population 25
4 Global Pain Management Therapeutics Market: Therapeutic Landscape 26
4.1 Fibromyalgia Market 26
4.1.1 Introduction 26
4.1.2 Sales Value 26
4.1.3 Patient Volume 28
4.1.4 Annual Cost of Therapy 29
4.1.5 Treatment Usage Patterns 30
4.1.6 Drivers for Fibromyalgia Pain Market 35
4.1.7 Restraints for Fibromyalgia Pain Market 36
4.1.8 Unmet Needs 36
4.2 Neuropathic Pain Market 36
4.2.1 Introduction 36
4.2.2 Sales Value 37
4.2.3 Patient Volume 38
4.2.4 Annual Cost of Therapy 39
4.2.5 Treatment Usage Patterns 40
4.2.6 Drivers for Neuropathic Pain Market 45
4.2.7 Restraints for Neuropathic Pain Market 46
4.2.8 Unmet Need 46
4.3 Migraine Market 46
4.3.1 Introduction 46
4.3.2 Sales Value 47
4.3.3 Patient Volume 48
4.3.4 Annual Cost of Therapy 49
4.3.5 Treatment Usage Patterns 50
4.3.6 Drivers for Migraine Market 55
4.3.7 Restraints for Migraine Market 55
4.3.8 Unmet Need 56
4.4 Cancer Pain Market 56
4.4.1 Introduction 56
4.4.2 Sales Value 56
4.4.3 Patient Volume 58
4.4.4 Annual Cost of Therapy 59
4.4.5 Treatment Usage Patterns 60
4.4.6 Drivers for Cancer Pain Market 64
4.4.7 Restraints for Cancer Pain Market 65
4.4.8 Unmet Need 65
4.5 Osteoarthritis Pain Market 65
4.5.1 Introduction 65
4.5.2 Sales Value 66
4.5.3 Patient Volume 67
4.5.4 Annual Cost of Therapy 68
4.5.5 Treatment Usage Patterns 69
4.5.6 Drivers for Osteoarthritis Pain Market 73
4.5.7 Restraints for Osteoarthritis Pain Market 74
4.5.8 Unmet Need 74
5 Global Pain Management Therapeutics Market: Geographical Landscape 75
5.1 Geographical Break-up 75
5.2 The US 77
5.2.1 Sales Value 77
5.2.2 Patient Volume 78
5.2.3 Annual Cost of Therapy 79
5.2.4 Treatment Usage Patterns 80
5.3 Top Five Countries in Europe 85
5.3.1 Sales Value 85
5.3.2 Patient Volume 86
5.3.3 Annual Cost of Therapy 87
5.3.4 Treatment Usage Patterns 88
5.4 Japan 93
5.4.1 Sales Value 93
5.4.2 Patient Volume 94
5.4.3 Annual Cost of Therapy 95
5.4.4 Treatment Usage Patterns 96
6 Global Pain Management Therapeutics Market: Pipeline Analysis 102
6.1 Introduction 102
6.1.1 Research and Development Pipeline Fibromyalgia 103
6.1.2 Research and Development Pipeline Neuropathic Pain 104
6.1.3 Research and Development Pipeline Migraine 105
6.1.4 Research and Development Pipeline Cancer Pain 106
6.1.5 Research and Development Pipeline Osteoarthritis Pain 106
6.2 Profiles of Key Late-Stage Drugs in the Pain Management Market 107
6.2.1 Droxopida 107
6.2.2 Xyrem 107
6.2.3 Vimpat (lacosamide) 107
6.2.4 Qutenza (capsaicin 8%) 108
6.2.5 Botox 109
6.2.6 Tezampanel 110
6.2.7 Nasalfent 110
6.2.8 PF-4383119 (Tanezumab) 111
7 Global Pain Management Therapeutics Market: Competitive Landscape 112
7.1 Market Share Analysis 112
7.2 Competitive Profiling 112
7.2.1 Pfizer, Inc. 114
7.2.2 Eli Lilly and Company 115
7.2.3 Johnson & Johnson 117
7.2.4 Endo Pharmaceuticals 119
7.2.5 Novartis AG 120
7.2.6 Merck & Co Inc 122
7.2.7 Cephalon, Inc. 123
8 Global Pain Management Therapeutics Market: Strategic Consolidations 125
8.1 Overview 125
8.1.1 Sanofi-Aventis Acquired 100% outstanding shares of Chattem, Inc in December 2009 127
8.1.2 Dainippon Sumitomo Pharma Acquired Sepracor, Inc. in October 2009 127
8.1.3 Raptor Pharmaceuticals and TorreyPines Therapeutics Merged in August 2009 127
8.1.4 Alexza Pharmaceuticals Acquired Symphony Allegro in June 2009 127
8.1.5 Anesiva and Arcion Therapeutics Merge in May 2009 127
8.1.6 Mylan Laboratories Acquired Matrix Laboratories Limited in March 2009 128
8.2 R&D Licensing Agreements 128
8.2.1 Deals by Indication 128
8.2.2 Deals by Phase 129
8.2.3 Deals by Geography 130
8.2.4 Deals by Value ($) 131
8.2.5 Preclinical and Discovery 131
8.2.6 Phase I 132
8.2.7 Phase II 132
8.2.8 Phase III 133
8.2.9 Approved and Regulatory Filing 134
9 Global Pain Management Therapeutics Market: Appendix 136
9.1 Market Definitions 136
9.2 Abbreviations 136
9.3 Research Methodology 137
9.3.1 Coverage 137
9.3.2 Secondary Research 138
9.3.3 Primary Research 138
9.3.4 Forecasts 138
9.3.5 Expert Panel Validation 140
9.4 Contact Us 141
9.5 Disclaimer 141
9.6 Sources 141
List of Tables
Table 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2009
Table 2: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2009-2016
Table 3: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2001-2009
Table 4: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2009-2016
Table 5: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2001-2009
Table 6: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2009-2016
Table 7: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009
Table 8: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016
Table 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016
Table 10: Pain Management Therapeutics Market, Global, Sales of Leading Drugs, 2009
Table 11: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2001-2009
Table 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2009-2016
Table 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2009
Table 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2009-2016
Table 15: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2009
Table 16: T Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2009-2016
Table 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009
Table 18: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2009-2016
Table 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2001-2009
Table 20: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2009-2016
Table 21: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2001-2009
Table 22: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2009-2016
Table 23: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2001-2009
Table 24: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2009-2016
Table 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2001-2009
Table 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2009-2016
Table 27: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn), 2001-2009
Table 28: Pain Management Therapeutics Market, Global, Migraine Diseases Population ($ bn), 2009-2016
Table 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2009
Table 30: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2009-2016
Table 31: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2009
Table 32: Pain Management Therapeutics Market, Global, Annual Cost of Migraine Treatment ($), 2001-2009
Table 33: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2001-2009
Table 34: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2009-2016
Table 35: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2001-2009
Table 36: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2009-2016
Table 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2009
Table 38: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2009-2016
Table 39: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2009
Table 40: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2009-2016
Table 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2001-2009
Table 42: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2009-2016
Table 43: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2001-2009
Table 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2009-2016
Table 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2001-2009
Table 46: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2009-2016
Table 47: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2009
Table 48: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2009-2016
Table 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2001-2009
Table 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2009-2016
Table 51: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009
Table 52: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016
Table 53: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2009
Table 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2009-2016
Table 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2009
Table 56: Pain Management Therapeutics Market, US, Patient Volume (million), 2009-2016
Table 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009
Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016
Table 59: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2001-2009
Table 60: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2009-2016
Table 61: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009
Table 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016
Table 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2009
Table 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2009-2016
Table 65: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009
Table 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016
Table 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2009
Table 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2009-2016
Table 69: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009
Table 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016
Table 71: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2001-2009
Table 72: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2009-2016
Table 73: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009
Table 74: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016
Table 75: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2009
Table 76: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions) , 2009-2016
Table 77: Pain Management Therapeutics Market, Global, Competitive Landscape, 2009
Table 78: Pain Management Therapeutics Market, Merck, Pipeline Products, December 2009
Table 79: Pain Management Therapeutics Market, Eli Lilly, Pipeline Products, 2010
Table 80: Pain Management Therapeutics Market, J&J, Pipeline Products, 2010
Table 81: Pain Management Therapeutics Market, Endo Pharmaceuticals, Pipeline Products, 2010
Table 82: Pain Management Therapeutics Market, Novartis, Pipeline Products, 2010
Table 83: Pain Management Therapeutics Market, Merck & Co, Inc., Pipeline Products, 2010
Table 84: Cephalon Inc. - Pain Pipeline Products, 2009
Table 85: Pain Management Therapeutics Market, Global, Major M&A Deals, 2009-2010
Table 86: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-2009
Table 87: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2009
Table 88: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2009
Table 89: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2009
Table 90: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs Which are Approved or Awaiting Approval, 2008-2009
List of Figures
Figure 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2000-2016 15
Figure 2: Pain Management Therapeutics Market, Global, Volume (Millions), 2001-2016 16
Figure 3: Pain Management Therapeutics Market, Global, Annual Cost of Therapy ($),
2000-2015 17
Figure 4: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 18
Figure 5: Pain Management Therapeutics Market, Global, Diseased Population (Millions),
2001-2016 19
Figure 6: Pain Management Therapeutics Market, Global, Treatment Seeking Population (Millions), 2001-2016 20
Figure 7: Pain Management Therapeutics Market, Global, Diagnosed Population (Millions), 2001-2016 21
Figure 8: Pain Management Therapeutics Market, Global, Prescription Population (Millions), 2001-2016 22
Figure 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 23
Figure 10: Pain Management Therapeutics Market, Global, Growth Parameters, 2009 25
Figure 11: Pain Management Therapeutics Market, Global, Sales Value by Indication (%) 2009 and 2016 26
Figure 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($ bn), 2001-2016 27
Figure 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2016 28
Figure 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2016 29
Figure 15: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 30
Figure 16: Pain Management Therapeutics Market, Global, Fibromyalgia Diseased Population (Millions), 2001-2016 32
Figure 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Seeking Population (Millions), 2001-2016 33
Figure 18: Pain Management Therapeutics Market, Global, Fibromyalgia Diagnosed Population (Millions), 2001-2016 34
Figure 19: Pain Management Therapeutics Market, Global, Fibromyalgia Prescription Population (Millions), 2001-2016 35
Figure 20: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2016 37
Figure 21: Pain Management Therapeutics Market, Global, Neuropathic Pain, Patient Volume (Millions), 2001-2016 38
Figure 22: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Therapy ($), 2001-2016 39
Figure 23: Pain Management Therapeutics Market, Global, Neuropathic Treatment Usage Patterns, 2001-2016 40
Figure 24: Pain Management Therapeutics Market, Global, Neuropathic Pain Diseased Population (Millions), 2001-2016 42
Figure 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Seeking Population (Millions), 2001-2016 43
Figure 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Diagnosed Population (Millions), 2001-2016 44
Figure 27: Pain Management Therapeutics Market, Global, Neuropathic Pain Prescription Population (Millions), 2001-2016 45
Figure 28: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn),
2001-2016 47
Figure 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2016 48
Figure 30: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2016 49
Figure 31: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions) , 2001-2016 50
Figure 32: Pain Management Therapeutics Market, Global, Migraine Diseased Population (Millions), 2001-2016 52
Figure 33: Pain Management Therapeutics Market, Global, Migraine Treatment Seeking Population (Millions), 2001-2016 53
Figure 34: Pain Management Therapeutics Market, Global, Migraine Diagnosed Population (Millions), 2001-2016 54
Figure 35: Pain Management Therapeutics Market, Global, Migraine Prescription Population (Millions), 2001-2016 55
Figure 36: Pain Management Therapeutics Market, Global, Cancer Pain Sales Value ($ bn),
2001-2016 57
Figure 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2016 58
Figure 38: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2016 59
Figure 39: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns, 2001-2016 60
Figure 40: Pain Management Therapeutics Market, Global, Cancer Pain Diseased Population, 2001-2016 61
Figure 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Seeking Population, 2001-2016 62
Figure 42: Pain Management Therapeutics Market, Global, Cancer Pain Diagnosed Population, 2001-2016 63
Figure 43: Pain Management Therapeutics Market, Global, Cancer Pain Prescription Population, 2001-2016 64
Figure 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($ bn), 2001-2016 66
Figure 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (Millions), 2001-2016 67
Figure 46: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2016 68
Figure 47: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns, 2001-2016 69
Figure 48: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diseased Population, 2001-2016 70
Figure 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Seeking Population, 2001-2016 71
Figure 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diagnosed Population, 2001-2016 72
Figure 51: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Prescription Population, 2001-2016 73
Figure 52: Pain Management Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 75
Figure 53: Pain Management Therapeutics Market, Global, Sales Value by Geography ($bn), 2001-2016 76
Figure 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2016 77
Figure 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2016 78
Figure 56: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 79
Figure 57: Pain Management Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 80
Figure 58: Pain Management Therapeutics Market, US, Diseased Population (Millions),
2001-2016 81
Figure 59: Pain Management Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 82
Figure 60: Pain Management Therapeutics Market, US, Diagnosed Population (Millions),
2001-2016 83
Figure 61: Pain Management Therapeutics Market, US, Prescription Population (Millions),
2001-2016 84
Figure 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value
($ bn), 2001-2016 85
Figure 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2016 86
Figure 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 87
Figure 65,: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2016 88
Figure 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 89
Figure 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions), 2001-2016 90
Figure 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 91
Figure 69: Pain Management Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 92
Figure 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 93
Figure 71: Pain Management Therapeutics Market, Japan, Patient Volume (million) , 2001-2016 94
Figure 72: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($),
2001-2016 95
Figure 73: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2016 96
Figure 74: Pain Management Therapeutics Market, Japan, Diseased Population (Millions),
2001-2016 98
Figure 75: Pain Management Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 99
Figure 76: Pain Management Therapeutics Market, Japan, Diagnosed Population (Millions),
2001-2016 100
Figure 77: Pain Management Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 101
Figure 78: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication, December 2009 102
Figure 79: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase, December 2009 102
Figure 80: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Fibromyalgia, March 2010 103
Figure 81: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Neuropathic Pain, March 2010 104
Figure 82: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Migraine, March 2010 105
Figure 83: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Cancer Pain, March 2010 106
Figure 84: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Osteoarthritis, March 2010 106
Figure 85: Pain Management Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 112
Figure 86: Pain Management Therapeutics Market, Global, Pfizer, Share of Key Pain Drugs Revenue, 2009 114
Figure 87: Pain Management Therapeutics Market, Global, Eli Lilly and Company, Share of Key Pain Drugs Revenue, 2009 116
Figure 88: Pain Management Therapeutics Market, Global, Johnson & Johnson, Share of Key Pain Drugs Revenue, 2009 118
Figure 89: Pain Management Therapeutics Market, Global, Endo Pharmaceuticals, Share of Key Pain Drugs Revenue, 2009 119
Figure 90: Pain Management Therapeutics Market, Global, Novartis, Share of Key Pain Drugs Revenue, 2009 121
Figure 91: Pain Management Therapeutics Market, Global, Merck & Co, Inc., Share of Key Pain Drugs Revenue, 2009 123
Figure 92: Pain Management Therapeutics Market, Global,Cephalon, Share of Key Pain Drugs Revenue, 2009 124
Figure 93: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Indication, 2008-2010 128
Figure 94: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Phase, 2008-2010 129
Figure 95: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-2010 130
Figure 96: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-2010, n=8 131
Figure 97: GBI Research Methodology, 2010 137
Figure 98: GBI Research Market Forecasting Model, 2010 140
Upcoming Reports:
|
Digital Cameras Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
The worldwide digital camera market is projected to grow to 138 million units by the year 2015 attributed by increasing demand for digital single lens reflex (SLR) cameras. Demand for digital SLR cameras is expected to witness significant growth in Asia Pacific due to the increasing income levels and growing prosperity of consumers.
Digital cameras represent one of the most popular segments of consumer electronics products market and it has benefited immensely from digitization of consumer electronics products. The global economic downturn hampered the growth of this...
|
|
Women Health Therapeutics Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecasts 2011 - 2017
By - Transparency Market Research
Market Size and Forecast
The women health therapeutics market is growing rapidly due to increasing awareness among patients & physicians and introduction of new therapies in the market. The women health therapeutics market was USD 14,530 million in 2010 and is expected to reach at USD 24,669 million by 2017 at an estimated CAGR of 7.9% during 2010-2017.
The menopause therapeutics market segment and post menopause osteoporosis market segment are expected to have maximum potential in women health therapeutics market during the forecast period....
|
|
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American market for congestive heart failure treatment devices accounted for $1.6 billion in 2010 and is expected to reach $3.2 billion by the year 2016 at the CAGR of 12.4% during the forecasted period. European market is forecasted to reach $1.5 billion at the CAGR of 7.5% by 2016. ...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- Global and China Piano Industry Report, 2012-2013
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
